Timing of Initiation of First-line Antiretroviral Therapy

  • Authors: Marshall J. Glesby, MD, PhD; Timothy J. Wilkin, MD, MPH (More Info)
  • Section Editor: Joel E. Gallant, MD, MPH
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • In general, early initiation of ART is recommended after starting active treatment for opportunistic infections
  • Data suggest that ART may be deferred in patients with cryptococcal meningitis, in whom early ART has not been shown to reduce morbidity and mortality in low-income countries[Makadzange 2010; Boulware 2014]
    • WHO recommends ART initiation should be deferred until there is evidence of a sustained clinical response to antifungal therapy and after 2-4 weeks of induction and consolidation treatment with amphotericin B–containing regimens combined with flucytosine or fluconazole or after 4-6 weeks of treatment with a high-dose oral fluconazole induction and consolidation regimen (Management Guidelines)[WHO CM]

Action required

Keywords: Initial Antiretroviral Therapy

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.